hormone replacement therapy (estrogen/progesterone)
FDA Approved
Description
Hormone replacement therapy with estrogen and progesterone is used to manage symptoms of premature ovarian failure and prevent long-term complications. It helps maintain bone density, cardiovascular health, and quality of life in women with early ovarian insufficiency. Treatment is typically continued until the natural age of menopause.
Indications & Therapeutic Use
premature ovarian failure, primary ovarian insufficiency, menopausal symptoms, osteoporosis prevention
Linked Diseases:
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
hormone replacement therapy (estrogen/progesterone)
| Generic Name | hormone replacement therapy (estrogen/progesterone) |
| Brands | 1 brand available |
| Active Ingredient | conjugated estrogens |
| Drug Class | premature ovarian failure |
| Manufacturer | Pfizer |
| Dosage Forms | oral tablet 0.3mg, 0.45mg, 0.625mg, 0.9mg, 1.25mg; transdermal patch; vaginal cream |
| Medical Code | G03CA57 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Countries | 8 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations9 Validated Nodes